HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 179 filers reported holding HAEMONETICS CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $11,220,000 | +32.1% | 279,106 | +19.0% | 0.01% | +30.0% |
| Q3 2016 | $8,493,000 | +26.1% | 234,562 | +1.0% | 0.01% | +11.1% |
| Q2 2016 | $6,733,000 | -8.6% | 232,269 | +10.3% | 0.01% | -10.0% |
| Q1 2016 | $7,366,000 | +10.9% | 210,590 | +2.2% | 0.01% | +11.1% |
| Q4 2015 | $6,644,000 | -0.0% | 206,087 | +0.2% | 0.01% | 0.0% |
| Q3 2015 | $6,647,000 | -22.5% | 205,668 | -0.8% | 0.01% | -18.2% |
| Q2 2015 | $8,575,000 | -0.3% | 207,331 | +8.2% | 0.01% | 0.0% |
| Q1 2015 | $8,604,000 | +21.6% | 191,531 | +1.3% | 0.01% | +22.2% |
| Q4 2014 | $7,075,000 | +6.1% | 189,073 | -1.0% | 0.01% | 0.0% |
| Q3 2014 | $6,666,000 | -0.5% | 190,888 | +0.6% | 0.01% | 0.0% |
| Q2 2014 | $6,697,000 | +21.0% | 189,820 | +11.8% | 0.01% | +12.5% |
| Q1 2014 | $5,536,000 | -22.0% | 169,855 | +0.9% | 0.01% | -27.3% |
| Q4 2013 | $7,095,000 | +4.2% | 168,403 | -1.4% | 0.01% | 0.0% |
| Q3 2013 | $6,809,000 | +1.7% | 170,740 | +5.4% | 0.01% | -8.3% |
| Q2 2013 | $6,698,000 | – | 161,983 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |